Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Connelly

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gynecologic Oncology|September 28, 2010
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancerErnest S Han, Robert A Burger, Kathleen M Darcy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2024
Timeline and outcomes of viral and fungal infections after chimeric antigen receptor T-cell therapy: a large database analysisJoseph Sassine, Nelson Iván Agudelo Higuita, Emily A Siegrist, et al.
International Journal of Cardiology|January 25, 2024
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohortAlessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma DevelopmentAlisha Kardian, Hua Sun, Siri Ippagunta, et al.
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gynecologic Oncology|September 28, 2010
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancerErnest S Han, Robert A Burger, Kathleen M Darcy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2024
Timeline and outcomes of viral and fungal infections after chimeric antigen receptor T-cell therapy: a large database analysisJoseph Sassine, Nelson Iván Agudelo Higuita, Emily A Siegrist, et al.
International Journal of Cardiology|January 25, 2024
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohortAlessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma DevelopmentAlisha Kardian, Hua Sun, Siri Ippagunta, et al.
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Pageof 2